These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2532059)

  • 1. Effect of interleukin-2 on the ex vivo growth of human myeloma cells.
    Peest D; de Vries I; Hölscher R; Leo R; Deicher H
    Cancer Immunol Immunother; 1989; 30(4):227-32. PubMed ID: 2532059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
    Kunicka JE; Platsoucas CD
    Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid generation of antiplasma cell activity in the bone marrow of myeloma patients by CD3-activated T cells.
    Massaia M; Attisano C; Peola S; Montacchini L; Omedé P; Corradini P; Ferrero D; Boccadoro M; Bianchi A; Pileri A
    Blood; 1993 Sep; 82(6):1787-97. PubMed ID: 8400233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
    Schmidt-Wolf IG; Negrin RS; Kiem HP; Blume KG; Weissman IL
    J Exp Med; 1991 Jul; 174(1):139-49. PubMed ID: 1711560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of RPMI 8226 human myeloma cells by peripheral blood lymphocytes.
    Amano T; Katagiri S; Tominaga N; Oritani K; Tamaki T; Kanayama Y; Yonezawa T; Tarui S
    Acta Haematol; 1992; 87(1-2):37-44. PubMed ID: 1350158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of anti-tumour activity by OKT3-stimulation in multiple myeloma: in vitro inhibition of autologous haemopoiesis.
    Attisano C; Bianchi A; Montacchini L; Carlesso N; Peola S; Bruno B; Roux V; Ferrero D; Gallo E; Boccadoro M
    Br J Haematol; 1994 Jul; 87(3):494-502. PubMed ID: 7993789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex.
    Massaia M; Bianchi A; Attisano C; Peola S; Redoglia V; Dianzani U; Pileri A
    Blood; 1991 Oct; 78(7):1770-80. PubMed ID: 1832993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating CD3- NK cells are more effective than CD3+ T cells in killing autologous melanoma cells.
    Azogui O; Avril MF; Margulis A; Guillard M; Caillou B; Prade M
    J Invest Dermatol; 1991 Sep; 97(3):425-9. PubMed ID: 1831465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human fetal liver-derived CD7+CD2lowCD3-CD56- clones that express CD3 gamma, delta, and epsilon and proliferate in response to interleukin-2 (IL-2), IL-3, IL-4, or IL-7: implications for the relationship between T and natural killer cells.
    Hori T; Phillips JH; Duncan B; Lanier LL; Spits H
    Blood; 1992 Sep; 80(5):1270-8. PubMed ID: 1381242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and immunological studies in advanced cancer patients sequentially treated with anti CD3 monoclonal antibody (OKT3) and interleukin-2.
    Borrione P; Montacchini L; Beggiato E; Pileri A; Bianchi A; Massaia M
    Leuk Lymphoma; 1996 Apr; 21(3-4):325-30. PubMed ID: 8726415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer patients' lymphocytes contain CD3+ CD4+ cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cells.
    Radrizzani M; Quaia M; Benedetti B; Andreola S; Vaglini M; Galligioni E; Fossati G; Parmiani G
    Cancer Immunol Immunother; 1989; 30(4):233-8. PubMed ID: 2574630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of lymphokine-activated killer activity in T-replete and T-cell-depleted human bone marrow by interleukin 4.
    Drobyski WR; LeFever AV; Truitt RL
    Exp Hematol; 1991 Oct; 19(9):950-7. PubMed ID: 1716592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of mononuclear cells to be used for hybrid monoclonal antibody-induced lysis of human ovarian carcinoma cells.
    Pupa SM; Canevari S; Fontanelli R; Ménard S; Mezzanzanica D; Lanzavecchia A; Colnaghi MI
    Int J Cancer; 1988 Sep; 42(3):455-9. PubMed ID: 2971021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma.
    Kunzmann V; Bauer E; Feurle J; Weissinger F; Tony HP; Wilhelm M
    Blood; 2000 Jul; 96(2):384-92. PubMed ID: 10887096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CD3 gamma delta + activated lymphocytes exhibit killer activity in vitro against autologous leukemic cells.
    Bensussan A; Lagabrielle JF; Castaigne S; Boisson N; Miclea JM; Benbunan M; Degos L
    Nouv Rev Fr Hematol (1978); 1989; 31(2):129-32. PubMed ID: 2528119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
    Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
    Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2-dependent generation of natural killer cells from bone marrow: role of MAC-1-, NK1-1- precursors.
    Migliorati G; Moraca R; Nicoletti I; Riccardi C
    Cell Immunol; 1992 May; 141(2):323-31. PubMed ID: 1533568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD3/Ti gamma A: a functional gamma-receptor complex expressed on human peripheral lymphocytes.
    Faure F; Jitsukawa S; Triebel F; Hercend T
    J Immunol; 1988 Mar; 140(5):1372-9. PubMed ID: 2964471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.
    Ochoa AC; Hasz DE; Rezonzew R; Anderson PM; Bach FH
    Cancer Res; 1989 Feb; 49(4):963-8. PubMed ID: 2521457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BSF-2/IL-6 does not augment Ig secretion but stimulates proliferation in myeloma cells.
    Tanabe O; Kawano M; Tanaka H; Iwato K; Asaoku H; Ishikawa H; Nobuyoshi M; Hirano T; Kishimoto T; Kuramoto A
    Am J Hematol; 1989 Aug; 31(4):258-62. PubMed ID: 2787116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.